Abarceo Pharma
PrivateLast Round
VC Round
Oct 27, 2025
Total Funding Raised
$2.56M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Abarceo Pharma is a biotechnology company developing a small molecule technology platform for the treatment of mitochondrial dysfunction, with an initial focus on Type 2 Diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abarceo Pharma Comparables
Compare Abarceo Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharmasaga Co., Ltd. | 85% | |
| MitoRx Therapeutics | 81% | |
| Mito BioPharma | 77% |
Abarceo Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 27, 2025 | ||||
| Private Equity | Dec 6, 2024 | ||||
| Seed | Mar 1, 2021 |
Key People
Founding team and executive leadership
Abarceo Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cardeon AB | Private Equity |
| Almi Invest AB | Seed |
| LU Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 27, 2025
Raised a VC Round with investment from lsi-epsilon.
- May 1, 2025
Monthly visitors grew 230% MoM, reaching 1.7K.
Abarceo Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Abarceo Pharma's valuation, stock price, and market status.
Is Abarceo Pharma a public or private company?
Abarceo Pharma is a private company.
What is the current stock price of Abarceo Pharma?
Abarceo Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Abarceo Pharma worth (valuation)?
Valuation information for Abarceo Pharma is not publicly available.
Can I buy Abarceo Pharma stock?
Abarceo Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Abarceo Pharma's last funding round?
Abarceo Pharma's most recent funding round was VC Round on October 27, 2025.
Who are the main investors in Abarceo Pharma?
Key investors in Abarceo Pharma include Cardeon AB, Almi Invest AB.
Will Abarceo Pharma IPO soon?
No public IPO plans have been announced for Abarceo Pharma.
How can I track Abarceo Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Abarceo Pharma's secondary market activity and sign up for updates.